Breast cancer risk from menopause hormones may last decades

by Marilynn MarchioneIn this May 6, 2010 file photo, a radiologist checks mammograms in in Los Angeles. Women who use certain types of hormones after menopause still have an increased risk of developi

Updated on: December 22,2023 12

Breast cancer risk from menopause hormones may last decades

by Marilynn MarchioneIn this May 6, 2010 file photo, a radiologist checks mammograms in in Los Angeles. Women who use certain types of hormones after menopause still have an increased risk of developi

Updated on:December 22,2023 12

Hair relaxers have been linked to cancer among Black women, litigation says. 'Nobody cares except us'

by Darcel Rockett, Chicago TribuneCredit: Unsplash/CC0 Public DomainLaTonya Shuler, 50, of Indianapolis, had planned to have children. But at age 32, she was diagnosed with uterine cancer. After six w

Updated on: January 04,2024 8

Hair relaxers have been linked to cancer among Black women, litigation says. 'Nobody cares except us'

by Darcel Rockett, Chicago TribuneCredit: Unsplash/CC0 Public DomainLaTonya Shuler, 50, of Indianapolis, had planned to have children. But at age 32, she was diagnosed with uterine cancer. After six w

Updated on:January 04,2024 8

Screening catches only one in seven cancers: Report

by Lori Solomon HealthDay ReporterOnly 14% of cancers diagnosed in the United States are diagnosed after the patient had a recommended screening test, according to a report released Dec. 14 by NORC at

Updated on: December 19,2023 7

Screening catches only one in seven cancers: Report

by Lori Solomon HealthDay ReporterOnly 14% of cancers diagnosed in the United States are diagnosed after the patient had a recommended screening test, according to a report released Dec. 14 by NORC at

Updated on:December 19,2023 7

Germany's BioNTech plans UK trial of mRNA cancer therapy

Scientists believe mRNA vaccines could be a game-changer against many diseases.German pharmaceutical company BioNTech, which developed a trailblazing COVID-19 vaccine, will trial a cancer treatment in

Updated on: December 20,2023 10

Germany's BioNTech plans UK trial of mRNA cancer therapy

Scientists believe mRNA vaccines could be a game-changer against many diseases.German pharmaceutical company BioNTech, which developed a trailblazing COVID-19 vaccine, will trial a cancer treatment in

Updated on:December 20,2023 10

New clue discovered as to how and why cancer cells spread

by Gillian Rutherford,University of AlbertaViscosity enhances cell migration and promotes an ARP2/3-mediated dense actin network at the leading edge.a,b, Speeds of MDA-MB-231 cells (a) and

Updated on: December 22,2023 16

New clue discovered as to how and why cancer cells spread

by Gillian Rutherford,University of AlbertaViscosity enhances cell migration and promotes an ARP2/3-mediated dense actin network at the leading edge.a,b, Speeds of MDA-MB-231 cells (a) and

Updated on:December 22,2023 16

Obesity is increasing people's risk of cancer. Why?

by Nancy Fliesler,Children's Hospital BostonAcomposite image representing a dormant breast tumor in the mammary fat pad of an obese mouse that is recruiting new blood vessels. Credit:

Updated on: December 22,2023 9

Obesity is increasing people's risk of cancer. Why?

by Nancy Fliesler,Children's Hospital BostonAcomposite image representing a dormant breast tumor in the mammary fat pad of an obese mouse that is recruiting new blood vessels. Credit:

Updated on:December 22,2023 9

Starting cancer treatment? You should discuss fertility first

by Violet Kieu and Kate Stern,The ConversationCredit: AI-generated imageNot all Australians with cancer are getting the fertility care they need.In 2022, it is predicted more than 8,200 Australi

Updated on: December 26,2023 12

Starting cancer treatment? You should discuss fertility first

by Violet Kieu and Kate Stern,The ConversationCredit: AI-generated imageNot all Australians with cancer are getting the fertility care they need.In 2022, it is predicted more than 8,200 Australi

Updated on:December 26,2023 12

FDA approval of 4-drug combination for front-line treatment of metastatic pancreatic cancer

by Denise Heady,University of California, Los AngelesKaplan–Meier estimates of overall survival (A) and progression-free survival (B) NALIRIFOX=liposomal irinotecan in combination with fluoroura

Updated on: March 22,2024 17

FDA approval of 4-drug combination for front-line treatment of metastatic pancreatic cancer

by Denise Heady,University of California, Los AngelesKaplan–Meier estimates of overall survival (A) and progression-free survival (B) NALIRIFOX=liposomal irinotecan in combination with fluoroura

Updated on:March 22,2024 17

New link between fatal muscle wasting disease gene and cancer discovered

byUniversity of PortsmouthCredit: Unsplash/CC0 Public DomainMutations of the gene encoding dystrophins have long been known to cause the debilitating muscle-wasting disease Duchenne muscular dys

Updated on: December 22,2023 6

New link between fatal muscle wasting disease gene and cancer discovered

byUniversity of PortsmouthCredit: Unsplash/CC0 Public DomainMutations of the gene encoding dystrophins have long been known to cause the debilitating muscle-wasting disease Duchenne muscular dys

Updated on:December 22,2023 6

Immunotherapy improves survival in metastatic or recurrent head and neck cancer

byEuropean Society for Medical OncologyProf Barbara Burtness, Yale School of Medicine and Co-Director, Development Therapeutics Research Program, Yale Cancer Center, New Haven, US, study author.

Updated on: December 18,2023 18

Immunotherapy improves survival in metastatic or recurrent head and neck cancer

byEuropean Society for Medical OncologyProf Barbara Burtness, Yale School of Medicine and Co-Director, Development Therapeutics Research Program, Yale Cancer Center, New Haven, US, study author.

Updated on:December 18,2023 18

Study of rare cancer identifies patients at highest risk of metastasis and those who would respond to immunotherapy

byThe Spanish National Cancer Research CentreCNIO researchers Bruna Calsina (left) and Mercedes Robledo. Credit: Laura M. Lombardía, CNIOPheochromocytoma is a rare tumor, with an incidence of th

Updated on: December 23,2023 13

Study of rare cancer identifies patients at highest risk of metastasis and those who would respond to immunotherapy

byThe Spanish National Cancer Research CentreCNIO researchers Bruna Calsina (left) and Mercedes Robledo. Credit: Laura M. Lombardía, CNIOPheochromocytoma is a rare tumor, with an incidence of th

Updated on:December 23,2023 13

Pembrolizumab With COPDAC-28 Consolidation Increases PET Negativity in Classical Hodgkin Lymphoma

August 29, 2023Kyle DohertyThe addition of pembrolizumab to COPDAC-28 consolidation may augment responses to treatment in pediatric and young adult patients with high-risk classical Hodgkin lymphoma w

Updated on: October 12,2023 202

Pembrolizumab With COPDAC-28 Consolidation Increases PET Negativity in Classical Hodgkin Lymphoma

August 29, 2023Kyle DohertyThe addition of pembrolizumab to COPDAC-28 consolidation may augment responses to treatment in pediatric and young adult patients with high-risk classical Hodgkin lymphoma w

Updated on:October 12,2023 202